BDX

BECTON DICKINSN
NYSE

Real-time Quotes | Nasdaq Last Sale

233.28
+7.88
+3.50%
Closed 18:06 04/02 EDT
OPEN
225.06
PREV CLOSE
225.40
HIGH
233.61
LOW
224.42
VOLUME
1.56M
TURNOVER
--
52 WEEK HIGH
286.72
52 WEEK LOW
197.75
MARKET CAP
63.26B
P/E (TTM)
97.39
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BDX stock price target is 269.46 with a high estimate of 290.00 and a low estimate of 234.00.

EPS

BDX News

More
  • The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SSL, HPQ and BDX
  • ACCESSWIRE · 19h ago
  • SHAREHOLDER ALERT: CLAIMSFILER REMINDS AAN, BDX, FLR, MGPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
  • GlobeNewswire · 1d ago
  • Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tivity Health, Tupperware Brands Corporation, Becton, Dickinson and Company, and Sterling Bancorp and Encourages Investors to Contact the Firm
  • GlobeNewswire · 1d ago
  • COVID-19-related actions - Healthcare
  • seekingalpha · 1d ago

Industry

Medical Equipment, Supplies & Distribution
+2.77%
Healthcare Equipment & Supplies
+3.33%

Hot Stocks

Symbol
Price
%Change

About BDX

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.
More

Webull offers kinds of Becton Dickinson and Co stock information, including NYSE:BDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDX stock news, and many more online research tools to help you make informed decisions.